Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins

American Journal of Medicine

Volumn 110, Issue 2, 2001, Pages 103-110

  Tribble, Diane L ^a,d   Rizzo, Manfredi ^a,b   Chait, Alan ^c   Lewis, Diane M ^a   Blanche, Patricia J ^a   Krauss, Ronald M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; COPPER; LOW DENSITY LIPOPROTEIN; PARINARIC ACID; UBIQUINOL 10; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MOLECULAR SIZE; MOLECULAR WEIGHT; OXIDATION REDUCTION POTENTIAL; PHENOTYPE; PRECURSOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; ANTIOXIDANTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACIDS, UNSATURATED; FEMALE; FLUORESCENT DYES; HUMANS; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; PHENOTYPE; REFERENCE VALUES;

EID: 0035254845     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00700-2     Document Type: Article

References (41)

1. Identification of multiple subclasses of plasma low density lipoproteins in normal subjects
2. Heterogeneity of serum low density lipoproteins in normal human subjects
3. Low density lipoprotein subclass and risk of myocardial infarction
4. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
5. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
6. Association of small, dense lipoprotein particles with incidence of coronary artery disease in men and women
7. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men
8. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk
9. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
10. Variations in oxidative susceptibility among six low density lipoprotein subfractions of varying size and density
11. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia
12. Susceptibility of small, dense low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype pattern B
13. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content
14. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans
15. Enhanced oxidative susceptibility of the surface monolayer in small, dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions
16. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B
17. Differing α-tocopherol oxidative lability and ascorbic acid sparing effects in buoyant and dense LDL
18. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations
19. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E and beta-carotene
20. Metabolism of VLDL and LDL subclasses
21. Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects
22. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project
23. Enzymatic determination of total serum cholesterol
24. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol
25. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
26. The isolation and quantitative analysis of lipoproteins
27. Autooxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
28. Determination of coenzyme Q10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection
29. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
30. Phosphorus assay in column chromatography
31. The determination of total cholesterol in serum by gas-liquid chromatography compared with two other methods
32. Lipoprotein heterogeneity and apolipoprotein B metabolism
33. Discrete subspecies of human LDL are heterogeneous in their interaction with the cellular LDL receptor
34. Differences in receptor binding of LDL subfractions
35. Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat
36. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease
37. LDL-subclass phenotypes, and triglyceride metabolism in non-insulin-dependent diabetes
38. Fatty acid composition of LDL influences its susceptibility to autooxidation
39. LDL oxidizability by copper correlates to its initial ubiquinol-10, and polyunsaturated fatty acid content
40. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation
41. Triglycerides and atherogenic lipoproteins: Rationale for lipid management